Endlyz Therapeutics, Inc.

CIK 1875514 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Endlyz Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 7, 2026D0001231919-26-000464
Jul 29, 2021D0001875514-21-000001